دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
The economic burden of inflammatory bowel disease
doi : 10.1016/S2468-1253(23)00075-4
Volume 8, Issue 5, May 2023, Page 391
Bringing dietary therapy for eosinophilic oesophagitis under scientific scrutiny
Stephen E Attwood
doi : 10.1016/S2468-1253(23)00041-9
Volume 8, Issue 5, May 2023, Pages 392-393
A substantial advance for screening of oesophageal cancer
Sanford M Dawsey, *Lucas C Duits
doi : 10.1016/S2468-1253(23)00065-1
Volume 8, Issue 5, May 2023, Pages 393-395
Reset after RESET: insights from a negative trial in coeliac disease
Heather J Galipeau, *Elena F Verdu
doi : 10.1016/S2468-1253(23)00007-9
Volume 8, Issue 5, May 2023, Pages 395-396
Managing inflammatory bowel disease: what to do when the best is unaffordable?
Rupa Banerjee*, Nalini Raghunathan, Partha Pal
doi : 10.1016/S2468-1253(23)00062-6
Volume 8, Issue 5, May 2023, Pages 396-398
Trends in alcohol-specific deaths in the UK and industry responses
Nason Maani, May CI van Schalkwyk, Mark Petticrew
doi : 10.1016/S2468-1253(23)00002-X
Volume 8, Issue 5, May 2023, Pages 398-400
Treatment de-escalation in Crohn's disease
*Cathy McShane, David Kevans
doi : 10.1016/S2468-1253(23)00073-0
Volume 8, Issue 5, May 2023, Page 401
Treatment de-escalation in Crohn's disease – Author's reply
Edouard Louis
doi : 10.1016/S2468-1253(23)00081-X
Volume 8, Issue 5, May 2023, Pages 401-402
Launch of the UN Group of Friends to eliminate hepatitis
Khaled A Ghaffar, John W Ward, Nida Ali, Mohamed Hassany
doi : 10.1016/S2468-1253(23)00040-7
Volume 8, Issue 5, May 2023, Page 402
$11 billion US hepatitis C elimination plan proposed
Bryant Furlow
doi : 10.1016/S2468-1253(23)00077-8
Volume 8, Issue 5, May 2023, Page 403
18th Congress of the European Crohn's and Colitis Organisation
Rob Brierley
doi : 10.1016/S2468-1253(23)00078-X
Volume 8, Issue 5, May 2023, Page 404
Research in Brief
Holly Baker
doi : 10.1016/S2468-1253(23)00076-6
Volume 8, Issue 5, May 2023, Page 405
Marc Rothenberg: passionately curious
Jennifer Thorley
doi : 10.1016/S2468-1253(23)00080-8
Volume 8, Issue 5, May 2023, Page 406
The War Inside
Georgia Bisbas
doi : 10.1016/S2468-1253(23)00079-1
Volume 8, Issue 5, May 2023, Page 407
One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial
Kara L Kliewer*, Nirmala Gonsalves*, Evan S Dellon*, David A Katzka*, Juan P Abonia, Seema S Aceves, Nicoleta C Arva, John A Besse, Peter A Bonis, Julie M Caldwell, Kelley E Capocelli, Mirna Chehade, Antonella Cianferoni, Margaret H Collins, Gary W Falk, Sandeep K Gupta, Ikuo Hirano, Jeffrey P Krischer, John Leung, Lisa J Martin, Paul Menard-Katcher, Vincent A Mukkada, Kathryn A Peterson, Tetsuo Shoda, Amanda K Rudman Spergel, Jonathan M Spergel, Guang-Yu Yang, Xue Zhang, Glenn T Furuta, Marc E Rothenberg
doi : 10.1016/S2468-1253(23)00012-2
Volume 8, Issue 5, May 2023, Pages 408-421
Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study
Gong Chen*, Ying Jin*, Wen-Long Guan*, Rong-Xin Zhang*, Wei-Wei Xiao*, Pei-Qiang Cai, Min Liu, Jun-Zhong Lin, Fu-Long Wang, Cong Li, Ting-Ting Quan, Shao-Yan Xi, Hui-Zhong Zhang, Zhi-Zhong Pan, Feng Wang†, Rui-Hua Xuâ€
doi : 10.1016/S2468-1253(22)00439-3
Volume 8, Issue 5, May 2023, Pages 422-431
Machine learning-based automated sponge cytology for screening of oesophageal squamous cell carcinoma and adenocarcinoma of the oesophagogastric junction: a nationwide, multicohort, prospective study
Ye Gao*, Lei Xin*, Han Lin*, Bin Yao, Tao Zhang, Ai-Jun Zhou, Shu Huang, Jian-Hua Wang, Ya-Dong Feng, Sheng-Hua Yao, Yan Guo, Tong Dang, Xian-Mei Meng, Zeng-Zhou Yang, Wan-Qi Jia, Hui-Fang Pang, Xiao-Juan Tian, Bin Deng, Jun-Ping Wang, Wen-Chuan Fan, Jun Wang, Li-Hong Shi, Guan-Yu Yang, Chang Sun, Wei Wang, Jun-Cai Zang, Song-Yang Li, Rui-Hua Shi†, Zhao-Shen Li†, Luo-Wei Wangâ€
doi : 10.1016/S2468-1253(23)00004-3
Volume 8, Issue 5, May 2023, Pages 432-445
Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study
Jason A Tye-Din,*A James M Daveson,*Gautam Goel, Kaela E Goldstein, Holly L Hand, Kristin M Neff, Alina Popp, Juha Taavela, Markku Maki, Jorma Isola, Leslie J Williams, Kenneth E Truitt, Robert P Anderson, on behalf of the RESET CeD Study Group
doi : 10.1016/S2468-1253(22)00428-9
Volume 8, Issue 5, May 2023, Pages 446-457
The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission
Johan Burisch, Mirabella Zhao, Selwyn Odes, Peter De Cruz, Severine Vermeire, Charles N Bernstein, Gilaad G Kaplan, Dana Duricova, Dan Greenberg, Hans O Melberg, Mamoru Watanabe, Hyeong Sik Ahn, Laura Targownik, Valérie E H Pittet, Vito Annese, KT Park, Konstantinos H Katsanos, Marte L Høivik, Zeljko Krznaric, MarÃa Chaparro, Edward V Loftus Jr, Peter L Lakatos, Javier P Gisbert, Willem Bemelman, Bjorn Moum, Richard B Gearry, Michael D Kappelman, Ailsa Hart, Marieke J Pierik, Jane M Andrews, Siew C Ng, Renata D’Inca, Pia Munkholm
doi : 10.1016/S2468-1253(23)00003-1
Volume 8, Issue 5, May 2023, Pages 458-492
